VLS Valneva SE

VALNEVA Declaration of shares and voting rights - January 31, 2023

VALNEVA Declaration of shares and voting rights - January 31, 2023

VALNEVA

Declaration of shares and voting rights

January 31, 2023

__________________________________________________________________________________________

Company name: VALNEVA

Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)

Regulated market of Euronext Paris - Compartment A

Declaration date: February 3, 2023

Number of shares

composing the share capital of Valneva
Total number of voting rights including suspended voting rights*Description of the changeDate on which this change was recognizedTotal number of voting rights excluding suspended voting rights**
 



138,346,968



ordinary shares with a par value of €0.15 each





160,952,293Double voting rights granted on 18,611 ordinary shares



 



Sale of 200 shares with double voting rights
Between January 8 & January 29, 2023



 



January 18, 2023
160,827,971

  

___________________________

* Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.

** Net (or exercisable at a General Meeting) voting rights.

Attachment



EN
03/02/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Valneva SE

Damien Choplain ... (+2)
  • Damien Choplain
  • Oscar Haffen Lamm

Valneva : FDA lifts age restriction on IXCHIQ

Valneva announced yesterday that the FDA has lifted its recommended pause on the use of IXCHIQ in individuals aged 60+, following updated safety data. This follows a similar decision by the EMA in July, which lifted temporary restrictions after a safety review. Despite regulatory clearance from bot

 PRESS RELEASE

Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungun...

Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information Saint Herblain (France), August 7, 2025 – (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of age and older and has approved updates to the Prescribing Information (PI) for IXCHIQ®. IXCHIQ® remains indicated in the United States for the prevention of disease caused by the Chikungunya Virus (CHIKV) in individuals 18 years of a...

 PRESS RELEASE

Valneva annonce la levée de l’arrêt temporaire de la FDA sur l’utilisa...

Valneva annonce la levée de l’arrêt temporaire de la FDA sur l’utilisation du vaccin contre le chikungunya IXCHIQ® chez les personnes âgées et une mise à jour des caractéristiques du produit Saint Herblain (France), le 7 août 2025 – (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui la levée de l’arrêt temporaire de l’agence de santé américaine Food and Drug Administration (FDA) sur l’utilisation d’IXCHIQ® (vaccin vivant atténué) chez les personnes âgées de 60 ans et plus ainsi que son accord sur une mise à jour des caractéristiques du produit....

 PRESS RELEASE

VALNEVA Declaration of shares and voting rights: July 31, 2025

VALNEVA Declaration of shares and voting rights: July 31, 2025 VALNEVA Declaration of shares and voting rights July 31, 2025__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris - Compartment B Declaration date: August 5, 2025 Number of shares composing the share capital of Valneva Total number of voting rights including suspended voting rights* Description of the change Date on which this change was recognized ...

 PRESS RELEASE

VALNEVA Déclaration d’actions et de droits de vote : 31 juillet 2025

VALNEVA Déclaration d’actions et de droits de vote : 31 juillet 2025 VALNEVA Déclaration d’actions et de droits de vote 31 juillet 2025__________________________________________________________________________________________ Dénomination sociale : VALNEVAAdresse du siège social : 6 rue Alain Bombard, 44800 Saint-HerblainMarché réglementé Euronext Paris - Compartiment B Date de la déclaration : 5 août 2025 Nombre d’actions composant le capital de Valneva Nombre total de droits de vote incluant les droits de vote suspendus* Origine de la variation Date à laquelle cette va...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch